Abstract:Many maternal traits are associated with a neonate's gestational duration, birth weight, and birth length. These birth outcomes are subsequently associated with late-onset health conditions. The causal mechanisms and the relative contributions of maternal and fetal genetic effects behind these observed associations are unresolved.Based on 10,734 mother–infant duos of European ancestry from the UK, Northern Europe, Australia, and North America, we constructed haplotype genetic scores using single-nucleotide polymorphisms (SNPs) known to be associated with adult height, body mass index (BMI), blood pressure (BP), fasting plasma glucose (FPG), and type 2 diabetes (T2D). Using these scores as genetic instruments, we estimated the maternal and fetal genetic effects underlying the observed associations between maternal phenotypes and pregnancy outcomes. We also used infant-specific birth weight genetic scores as instrument and examined the effects of fetal growth on pregnancy outcomes, maternal BP, and glucose levels during pregnancy. The maternal nontransmitted haplotype score for height was significantly associated with gestational duration (p = 2.2 × 10−4). Both maternal and paternal transmitted height haplotype scores were highly significantly associated with birth weight and length (p < 1 × 10−17). The maternal transmitted BMI scores were associated with birth weight with a significant maternal effect (p = 1.6 × 10−4). Both maternal and paternal transmitted BP scores were negatively associated with birth weight with a significant fetal effect (p = 9.4 × 10−3), whereas BP alleles were significantly associated with gestational duration and preterm birth through maternal effects (p = 3.3 × 10−2 and p = 4.5 × 10−3, respectively). The nontransmitted haplotype score for FPG was strongly associated with birth weight (p = 4.7 × 10−6); however, the glucose-increasing alleles in the fetus were associated with reduced birth weight through a fetal effect (p = 2.2 × 10−3). The haplotype scores for T2D were associated with birth weight in a similar way but with a weaker maternal effect (p = 6.4 × 10−3) and a stronger fetal effect (p = 1.3 × 10−5). The paternal transmitted birth weight score was significantly associated with reduced gestational duration (p = 1.8 × 10−4) and increased maternal systolic BP during pregnancy (p = 2.2 × 10−2). The major limitations of the study include missing and heterogenous phenotype data in some data sets and different instrumental strength of genetic scores for different phenotypic traits.We found that both maternal height and fetal growth are important factors in shaping the duration of gestation: genetically elevated maternal height is associated with longer gestational duration, whereas alleles that increase fetal growth are associated with shorter gestational duration. Fetal growth is influenced by both maternal and fetal effects and can reciprocally influence maternal phenotypes: taller maternal stature, higher maternal BMI, and higher maternal blood glucose are associated with larger birth size through maternal effects; in the fetus, the height- and metabolic-risk–increasing alleles are associated with increased and decreased birth size, respectively; alleles raising birth weight in the fetus are associated with shorter gestational duration and higher maternal BP. These maternal and fetal genetic effects may explain the observed associations between the studied maternal phenotypes and birth outcomes, as well as the life-course associations between these birth outcomes and adult phenotypes.

On the importance of birth weight in relation to disease risk in later life

Causal Association Between Birth Weight and Atrial Fibrillation: Evidence from a Two-Sample Mendelian Randomization Analysis

Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs

Genetic analyses of birthweight and cardiovascular disease

Maternal and Fetal Origins of Offspring Blood Pressure: Statistical Analysis Using Genetic Correlation and Genetic Risk Score-Based Mendelian Randomization.

Lower birth weight is linked to poorer cardiovascular health in middle-aged population-based adults

Opposite Causal Effects of Birthweight on Myocardial Infarction and Atrial Fibrillation and the Distinct Mediating Pathways: a Mendelian Randomization Study

Association Between Paternal Age and Birth Weight in Preterm and Full-Term Birth: A Retrospective Study

Relationship Between Birth Weight and Chronic Kidney Disease: Evidence from Systematics Review and Two-Sample Mendelian Randomization Analysis.

Abstract P191: Birth Weight and Risk of Hypertension: A Mendelian Randomization Study of 183433 Individuals from 60 Studies

Maternal Hypertension Increases Risk of Preeclampsia and Low Fetal Birthweight: Genetic Evidence From a Mendelian Randomization Study

Is lower birthweight truly causal for increased cardiovascular risk?

Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors

Birth Weight, Cardiometabolic Factors, and Coronary Heart Disease: A Mendelian Randomization Study

Dissecting maternal and fetal genetic effects underlying the associations between maternal phenotypes, birth outcomes, and adult phenotypes: A mendelian-randomization and haplotype-based genetic score analysis in 10,734 mother–infant pairs

Associations of Birth Weight and Later Life Lifestyle Factors with Risk of Cardiovascular Disease in the USA: A Prospective Cohort Study.

Association of maternal birth weight and maternal preterm birth with subsequent risk for adverse reproductive outcomes: The Women's Health Initiative

Birthweight influences liver structure, function and disease risk: Evidence of a causal association

Association of birthweight with diabetes, hypertension, and ischemic heart disease in young adulthood: a retrospective cohort study

Fetal malnutrition and long-term outcomes

Both indirect maternal and direct fetal genetic effects reflect the observational relationship between higher birth weight and lower adult bone mass